GSK rumors

[anonymous]

Merger with GSk?

 

[anonymous]

0 chance

 

[anonymous]

Merger with GSk?

CRM already works for GSK

 

[anonymous]

CRM already works for GSK

HA! So true! And exactly why CRM is the dumpster of this company and everyone is miserable.

 

[anonymous]

With all the cash we’re sitting on we’re buying somebody but I’d be surprised if it was GSK.

 

[anonymous]

With all the cash we’re sitting on we’re buying somebody but I’d be surprised if it was GSK.

 

[anonymous]

Where’s the link

 

[anonymous]

Merger with GSk?

January 31, 2024 just kickoff?

 

[anonymous]

January 31, 2024 just kickoff?

No, just townhall where Vas announces Q4 results and BPF for salaried employees.

 

[anonymous]

More likely to buy Amgen

 

[anonymous]

With all the cash we’re sitting on we’re buying somebody but I’d be surprised if it was GSK.

BINGO
https://www.reuters.com/breakingviews/swiss-pharma-mega-deal-has-healthy-prognosis-2023-12-19/

 

[anonymous]

BINGO
https://www.reuters.com/breakingviews/swiss-pharma-mega-deal-has-healthy-prognosis-2023-12-19/

Best merger hypothesis ever ;-)

 

[anonymous]

I would bet roche or amgen

 

[anonymous]

Amgen or BMS is what I've heard for over a year now

 

[anonymous]

Veeva CRM showed interesting data after sync today.

 

[anonymous]

Veeva CRM showed interesting data after sync today.

What was interesting about it?

 

[anonymous]

What was interesting about it?

It included excerpts from Metamorphoses

 

[anonymous]

What was interesting about it?

Individual information gathered by sales fore disappeared. Just check it out. Maintenance or due dilligence?

 

[anonymous]

Amgen or BMS is what I've heard for over a year now

Amgen doesn’t have the money. They are cash poor after buying Horizon which just closed 3 months ago.

 

[anonymous]

Amgen doesn’t have the money. They are cash poor after buying Horizon which just closed 3 months ago.

damn thing sent too soon.

Anyway.,.Novartis wouldn’t attempt to buy them given their current financial position. Plus, the head of the FTC committed is a whacko and will try to block it. She tried to block the Horizon/Amgen deal despite having zero drugs treating the same disease - or any in the pipeline that are anywhere close to market. Her reasoning was that it would increase Amgen’s ability to bundle with PBMs which was hilarious given that Horizon meds are infused & 90% of the time get covered under medical benefit, not pharmacy, Plus, they’re rare disease drugs so they don’t account for much spend overall. Multiple committed members have quit in protest of her nuttiness. I can’t see any mergers/buyouts of such a magnitude until next year at the earliest. Wait out the election and hope that check gets the boot.